Reckitt Benckiser Group (RB) PT Set at GBX 8,200 by Sanford C. Bernstein

Sanford C. Bernstein set a GBX 8,200 ($107.15) target price on Reckitt Benckiser Group (LON:RB) in a report issued on Thursday, October 4th. The firm currently has a buy rating on the stock.

Other equities analysts have also recently issued reports about the stock. JPMorgan Chase & Co. set a GBX 7,000 ($91.47) price objective on shares of Reckitt Benckiser Group and gave the stock a buy rating in a research report on Monday, July 23rd. Cfra set a GBX 7,500 ($98.00) price objective on shares of Reckitt Benckiser Group and gave the stock a buy rating in a research report on Monday, July 30th. Jefferies Financial Group set a GBX 6,800 ($88.85) price objective on shares of Reckitt Benckiser Group and gave the stock a neutral rating in a research report on Wednesday, August 1st. Shore Capital restated a hold rating on shares of Reckitt Benckiser Group in a report on Friday, July 27th. Finally, Kepler Capital Markets set a GBX 6,300 ($82.32) price target on shares of Reckitt Benckiser Group and gave the company a neutral rating in a report on Friday, July 27th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and ten have issued a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of GBX 7,115.48 ($92.98).

Reckitt Benckiser Group stock traded down GBX 127 ($1.66) during mid-day trading on Thursday, hitting GBX 6,464 ($84.46). The company’s stock had a trading volume of 534,508 shares, compared to its average volume of 1,720,000. Reckitt Benckiser Group has a twelve month low of GBX 5,562 ($72.68) and a twelve month high of GBX 8,110.43 ($105.98).

The company also recently announced a dividend, which was paid on Thursday, September 27th. Shareholders of record on Thursday, August 16th were given a dividend of GBX 70.50 ($0.92) per share. This represents a yield of 1.04%. The ex-dividend date of this dividend was Thursday, August 16th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.

Recommended Story: How Important is Technical Analysis of Stocks

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply